DEVELOPMENT AND VALIDATION OF RP-HPLC METHOD FOR THE ESTIMATION OF ANTIRETROVIRAL DRUGS AND THEIR PHARMACEUTICAL FORMULATIONS

Quick, exact, precise, particular & basic RP-HPLC technique was created & accepted for synchronous estimation of TENO & EMTRI in its business plans by utilizing plasma. Agilent 1100 arrangement HPLC Auto sampler High execution fluid chromatograph with U. V-Visible indicator was utilized all through examination, with versatile stage piece of Methanol: Phosphate cushion [ 68: 32 % v/v]. Stream rate was kept up 1.0 ml min-1 with UV location at 259 nm. Maintenance time of TENO & EMTRI were 5.54 +/- 0.02 & 9.48 +/- 0.02 minutes individually. Linearity was seen over focus scope of 4-40 mu g/ml for both medications. Lower breaking points of identification were observed to be 0.1571 mu g/ml & 0.1622 mu g/ml & cutoff points of measurement qualities were observed to be 0.4760 mu g/ml & 0.4917 mu g/ml for TENO & EMTRI individually for crude material & definitions. Precision of proposed strategy was dictated by recuperation examines & observed to be 98.12 to 101.31 % for TENO & EMTRI individually. Business plans & research center arranged blends were effectively broke down utilizing created strategy. Proposed technique was approved for different ICH parameters like linearity, farthest point of recognition, cutoff points of evaluation, exactness, accuracy, specificity, & extent & framework reasonableness.